{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:49:03Z","timestamp":1792838943943,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.cgh.2016.03.041","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T11:39:13Z","timestamp":1459856353000},"page":"1207-1215.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Features of Severe Liver Disease With Portal Hypertension in\u00a0Patients With Cystic Fibrosis"],"prefix":"10.1016","volume":"14","author":[{"given":"Jaclyn R.","family":"Stonebraker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Y.","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda G.","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Corvol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Durie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2016.03.041_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jcf.2014.05.013","article-title":"Outcome in patients with cystic fibrosis liver disease","volume":"14","author":"Rowland","year":"2015","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.cgh.2016.03.041_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCP.0b013e32834ba899","article-title":"Nongenetic influences on cystic fibrosis outcomes","volume":"17","author":"Schechter","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.cgh.2016.03.041_bib3","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/jama.2009.1295","article-title":"Genetic modifiers of liver disease in cystic fibrosis","volume":"302","author":"Bartlett","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2016.03.041_bib4","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report","volume":"153","author":"Farrell","year":"2008","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.cgh.2016.03.041_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MPG.0b013e31818fc63b","article-title":"Age- and sex-related reference ranges of alanine aminotransferase levels in children: European paediatric HCV network","volume":"49","author":"England","year":"2009","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2016.03.041_bib6","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1053\/j.gastro.2009.12.052","article-title":"SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease","volume":"138","author":"Schwimmer","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.03.041_bib7","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1373\/clinchem.2011.177741","article-title":"Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children","volume":"58","author":"Colantonio","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.cgh.2016.03.041_bib8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.03.041_bib9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.03.041_bib10","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/hep.28016","article-title":"Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy validated pediatric cystic fibrosis liver disease","volume":"62","author":"Leung","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.03.041_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcf.2012.05.001","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis","volume":"11","author":"Ooi","year":"2012","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.cgh.2016.03.041_bib12","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2004.08.006","article-title":"Epidemiology of liver disease in cystic fibrosis: a longitudinal study","volume":"41","author":"Lamireau","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.03.041_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0022-3476(94)70361-2","article-title":"Analysis of risk factors for the development of liver disease associated with cystic fibrosis","volume":"124","author":"Colombo","year":"1994","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.cgh.2016.03.041_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11894-011-0185-9","article-title":"Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation","volume":"13","author":"van der Doef","year":"2011","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.cgh.2016.03.041_bib15","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O'Sullivan","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2016.03.041_bib16","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/me.2005-0489","article-title":"Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis","volume":"20","author":"Clodfelter","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cgh.2016.03.041_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev.ph.45.030183.000345","article-title":"Sexual dimorphism in the liver","volume":"45","author":"Roy","year":"1983","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.cgh.2016.03.041_bib18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/096120339900800510","article-title":"Gender differences in some host defense mechanisms","volume":"8","author":"Spitzer","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.cgh.2016.03.041_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/adc.81.2.129","article-title":"The evolution of liver disease in cystic fibrosis","volume":"81","author":"Ling","year":"1999","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.cgh.2016.03.041_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MPG.0000000000000600","article-title":"Circulating microRNAs as noninvasive diagnostic biomarkers of liver disease in children with cystic fibrosis","volume":"60","author":"Cook","year":"2015","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2016.03.041_bib21","doi-asserted-by":"crossref","first-page":"e58955","DOI":"10.1371\/journal.pone.0058955","article-title":"Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease","volume":"8","author":"Rath","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2016.03.041_bib22","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/liv.12113","article-title":"Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease","volume":"33","author":"Kitson","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2016.03.041_bib23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jhep.2004.06.032","article-title":"Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease","volume":"41","author":"Pereira","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.03.041_bib24","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1053\/j.gastro.2011.08.049","article-title":"A\u00a0clinical prediction rule and platelet count predict esophageal varices in children","volume":"141","author":"Gana","year":"2011","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2016.03.041_bib25","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray","year":"2011","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.cgh.2016.03.041_bib26","first-page":"CD000222","article-title":"Ursodeoxycholic acid for cystic fibrosis-related liver disease","volume":"12","author":"Cheng","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2016.03.041_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcf.2011.08.002","article-title":"Ursodeoxycholic acid in cystic fibrosis-associated liver disease","volume":"11","author":"Ooi","year":"2012","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.cgh.2016.03.041_bib28","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.03.041_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/lt.22240","article-title":"Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data","volume":"17","author":"Mendizabal","year":"2011","journal-title":"Liver Transpl"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516300167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516300167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:19:52Z","timestamp":1761542392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356516300167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1542356516300167"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2016.03.041","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Features of Severe Liver Disease With Portal Hypertension in\u00a0Patients With Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2016.03.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the AGA Institute","name":"copyright","label":"Copyright"}]}}